Literature DB >> 14723914

"Iceland Inc."?: On the ethics of commercial population genomics.

Jon F Merz1, Glenn E McGee, Pamela Sankar.   

Abstract

A detailed analysis of the Icelandic commercial population-wide genomics database project of deCODE Genetics was performed for the purpose of providing ethics insights into public/private efforts to develop genetic databases. This analysis examines the moral differences between the general case of governmental collection of medical data for public health purposes and the centralized collection planned in Iceland. Both the process of developing the database and its design vary in significant ways from typical government data collection and analysis activities. Because of these differences, the database may serve the interests of deCODE more than it serves the interests of the public, undermining the claim that presumed consent for this data collection and its proprietary use is ethical. We believe that there is an evolving consensus that informed consent of participants must be secured for population-based genetics databases and research. The Iceland model provides an informative counterexample that holds key ethics lessons for similar ventures.

Entities:  

Keywords:  Analytical Approach; Biomedical and Behavioral Research; Genetics and Reproduction; deCode Genetics

Mesh:

Year:  2004        PMID: 14723914     DOI: 10.1016/s0277-9536(03)00256-9

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  2 in total

1.  Infrastructural capital in the Israeli vaccination campaign against COVID-19.

Authors:  Omri Tubi
Journal:  Soc Sci Med       Date:  2022-05-09       Impact factor: 5.379

2.  Comparison of participant information and informed consent forms of five European studies in genetic isolated populations.

Authors:  Deborah Mascalzoni; A Cecile J W Janssens; Alison Stewart; Peter Pramstaller; Ulf Gyllensten; Igor Rudan; Cornelia M van Duijn; James F Wilson; Harry Campbell; Ruth M C Quillan
Journal:  Eur J Hum Genet       Date:  2009-10-14       Impact factor: 4.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.